Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors - A systematic review

Danish Medical Bulletin

Volumn 58, Issue 9, 2011, Pages

  Fenger Grøn, Jesper ^a   Thomsen, Morten ^b   Andersen, Kristian Skytte ^b   Nielsen, Rasmus Gaardskær ^c  

^a LILLEBAELT HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

APPETITE; AROUSAL; ARTICLE; BREATHING; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; HUMAN; MOOD; PREGNANCY; PULMONARY HYPERTENSION; SEROTONIN UPTAKE; SYSTEMATIC REVIEW; TEMPERATURE; CARDIOVASCULAR MALFORMATION; CHEMICALLY INDUCED DISORDER; CHILD; DEPRESSION; DRUG EFFECT; FEMALE; FETUS; INFANT; NEWBORN; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; REVIEW; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR ABNORMALITIES; CHILD; DEPRESSIVE DISORDER; FEMALE; FETUS; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS;

EID: 80052533818     PISSN: None     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lattimore KA, Donn SM, Kaciroti N et al. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005;25:595-604.
2. Tuccori M, Testi A, Antonioli L et al. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin Ther 2009;1:1426-53.
3. Antidepressiv medicin og graviditet. url http://irf.dk/dk/aendrede_retningslinjer/antidepressiv_medicin_og_graviditet.htm (27 May 2011).
4. Forbrug af antidepressive midler i forbindelse med graviditet og fødsel 1997-2006. www.sst.dk/publ/tidsskrifter/nyetal/pdf/2007/20_07.pdf. (1Nov 2010).
5. www.medstat.dk (1 Nov 2010).
6. Borue X, Chen J, Condron BG. Developmental effects of SSRIs: lessons learned from animal studies. Int J Dev Neurosci 2007;25:341-7.
7. Fleschler R, Peskin MF. Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: a review. MCN Am J Matern Child Nurs 2008;33:355-61.
8. Ellfolk M, Malm H. Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). Reprod Toxicol 2010;30:249-60.
9. Chambers CD, Johnson KA, Dick LM et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-5.
10. Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010;40:1723-33.
11. Oberlander TF, Papsdorf M, Brain UM et al. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med 2010;164:444-51.
12. Oberlander TF, Warburton W, Misri S et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006;63:898-906.
13. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009;163:949-54.
14. Udechuku A, Nguyen T, Hill R et al. Antidepressants in pregnancy: a systematic review. Aust N Z J Psychiatry 2010;44:978-96.
15. Laine K, Heikkinen T, Ekblad U et al. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003;60:720-6.
16. Cohen LS, Heller VL, Bailey JW et al. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry 2000;48:996-1000.
17. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005;106:1289-96.
18. Jordan AE, Jackson GL, Deardorff D et al. Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome. J Matern Fetal Neonatal Med 2008;21:745-51.
19. Lennestal R, Kallen B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 2007;27:607-13.
20. Oberlander TF, Misri S, Fitzgerald CE et al. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004;65:230-7.
21. Moses-Kolko EL, Bogen D, Perel J et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005;293:2372-2383.
22. Ferreira E, Carceller AM, Agogue C et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 2007;119:52-9.
23. Levinson-Castiel R, Merlob P, Linder N et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006;160:173-6.
24. Klinger G, Merlob P. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Isr J Psychiatry Relat Sci 2008;45:107-13.
25. Warburton W, Hertzman C, Oberlander TF. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand 2010;121:471-9.
26. Oberlander TF, Bonaguro RJ, Misri S et al. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry 2008;13:65-73.
27. Austin MP. To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects. Psychol Med 2006;36:1663-70.
28. Sivojelezova A, Shuhaiber S, Sarkissian L et al. Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005;193:2004-9.
29. Galbally M, Lewis AJ, Lum J et al. Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study. Aust N Z J Psychiatry 2009;43:846-854.
30. Oberlander TF, Warburton W, Misri S et al. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 2008;192:338-343.
31. Nulman I, Koren G. The safety of fluoxetine during pregnancy and lactation. Teratology 1996;53:304-8.
32. Nulman I, Rovet J, Stewart DE et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002;159:1889-1895.
33. Nulman I, Rovet J, Stewart DE et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-262.
34. Oberlander TF, Grunau RE, Fitzgerald C et al. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005;115:411-25.
35. Casper RC, Fleisher BE, Lee-Ancajas JC et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003;142:402-8.
36. Pedersen LH, Henriksen TB, Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 2010;125:e600-e608.
37. Heikkinen T, Ekblad U, Kero P et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;72:184-191.
38. Oberlander TF, Grunau R, Mayes L et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum Dev 2008;84:689-697.
39. Oberlander TF, Eckstein GR, Fitzgerald C et al. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res 2002;51:443-453.
40. Oberlander TF, Reebye P, Misri S et al. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med 2007;161:22-29.